112 related articles for article (PubMed ID: 19782714)
21. The potential effect and mechanism of high-mobility group box 1 protein on regulatory T cell-mediated immunosuppression.
Zhang Y; Yao YM; Huang LF; Dong N; Yu Y; Sheng ZY
J Interferon Cytokine Res; 2011 Feb; 31(2):249-57. PubMed ID: 21087077
[TBL] [Abstract][Full Text] [Related]
22. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
[TBL] [Abstract][Full Text] [Related]
23. The frequency of peripheral blood CD4+ CD25high FoxP3+ and CD4+ CD25- FoxP3+ regulatory T cells in normal pregnancy and pre-eclampsia.
Toldi G; Saito S; Shima T; Halmos A; Veresh Z; Vásárhelyi B; Rigó J; Molvarec A
Am J Reprod Immunol; 2012 Aug; 68(2):175-80. PubMed ID: 22510013
[TBL] [Abstract][Full Text] [Related]
24. Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease.
Su H; Ye DQ; Wang BL; Fang XH; Chen J; Wang Q; Li WX; Zhang N
Br J Dermatol; 2008 Jun; 158(6):1197-209. PubMed ID: 18410422
[TBL] [Abstract][Full Text] [Related]
25. CD4 blockade directly inhibits mouse and human CD4(+) T cell functions independent of Foxp3(+) Tregs.
Mayer CT; Huntenburg J; Nandan A; Schmitt E; Czeloth N; Sparwasser T
J Autoimmun; 2013 Dec; 47():73-82. PubMed ID: 24055067
[TBL] [Abstract][Full Text] [Related]
26. Enhanced functionality of CD4+CD25(high)FoxP3+ regulatory T cells in the peripheral blood of patients with prostate cancer.
Yokokawa J; Cereda V; Remondo C; Gulley JL; Arlen PM; Schlom J; Tsang KY
Clin Cancer Res; 2008 Feb; 14(4):1032-40. PubMed ID: 18281535
[TBL] [Abstract][Full Text] [Related]
27. Increase in activated Treg in TIL in lung cancer and in vitro depletion of Treg by ADCC using an antihuman CCR4 mAb (KM2760).
Kurose K; Ohue Y; Sato E; Yamauchi A; Eikawa S; Isobe M; Nishio Y; Uenaka A; Oka M; Nakayama E
J Thorac Oncol; 2015 Jan; 10(1):74-83. PubMed ID: 25325779
[TBL] [Abstract][Full Text] [Related]
28. Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry.
Santegoets SJ; Dijkgraaf EM; Battaglia A; Beckhove P; Britten CM; Gallimore A; Godkin A; Gouttefangeas C; de Gruijl TD; Koenen HJ; Scheffold A; Shevach EM; Staats J; Taskén K; Whiteside TL; Kroep JR; Welters MJ; van der Burg SH
Cancer Immunol Immunother; 2015 Oct; 64(10):1271-86. PubMed ID: 26122357
[TBL] [Abstract][Full Text] [Related]
29. Altered Suppressor Function of Regulatory T Cells in Type 1 Diabetes.
Aghili B; Amirzargar AA; Rajab A; Rabbani A; Sotoudeh A; Assadiasl S; Larijani B; Massoud A
Iran J Immunol; 2015 Dec; 12(4):240-51. PubMed ID: 26714416
[TBL] [Abstract][Full Text] [Related]
30. A robust immune system conditions the response to abagovomab (anti-idiotypic monoclonal antibody mimicking the CA125 protein) vaccination in ovarian cancer patients.
Battaglia A; Fossati M; Buzzonetti A; Scambia G; Fattorossi A
Immunol Lett; 2017 Nov; 191():35-39. PubMed ID: 28919454
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-2 administration alters the CD4+FOXP3+ T-cell pool and tumor trafficking in patients with ovarian carcinoma.
Wei S; Kryczek I; Edwards RP; Zou L; Szeliga W; Banerjee M; Cost M; Cheng P; Chang A; Redman B; Herberman RB; Zou W
Cancer Res; 2007 Aug; 67(15):7487-94. PubMed ID: 17671219
[TBL] [Abstract][Full Text] [Related]
32. FoxP3+ regulatory T cells in peripheral blood of patients with epithelial ovarian cancer.
Erfani N; Hamedi-Shahraki M; Rezaeifard S; Haghshenas M; Rasouli M; Samsami Dehaghani A
Iran J Immunol; 2014 Jun; 11(2):105-12. PubMed ID: 24975967
[TBL] [Abstract][Full Text] [Related]
33. Identification of a human Th1-like IFNγ-secreting Treg subtype deriving from effector T cells.
Venigalla RK; Guttikonda PJ; Eckstein V; Ho AD; Sertel S; Lorenz HM; Tretter T
J Autoimmun; 2012 Dec; 39(4):377-87. PubMed ID: 22824211
[TBL] [Abstract][Full Text] [Related]
34. Frequency and activation of CD4+CD25 FoxP3+ regulatory T cells in peripheral blood from children with atopic allergy.
Stelmaszczyk-Emmel A; Zawadzka-Krajewska A; Szypowska A; Kulus M; Demkow U
Int Arch Allergy Immunol; 2013; 162(1):16-24. PubMed ID: 23817221
[TBL] [Abstract][Full Text] [Related]
35. Induction of inducible CD4+CD25+Foxp3+ regulatory T lymphocytes by porcine reproductive and respiratory syndrome virus (PRRSV).
Wongyanin P; Buranapraditkun S; Chokeshai-Usaha K; Thanawonguwech R; Suradhat S
Vet Immunol Immunopathol; 2010 Feb; 133(2-4):170-82. PubMed ID: 19709757
[TBL] [Abstract][Full Text] [Related]
36. Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis.
Sugimoto N; Oida T; Hirota K; Nakamura K; Nomura T; Uchiyama T; Sakaguchi S
Int Immunol; 2006 Aug; 18(8):1197-209. PubMed ID: 16772372
[TBL] [Abstract][Full Text] [Related]
37. The immunoregulatory role of CD4⁺ FoxP3⁺ CD25⁻ regulatory T cells in lungs of mice infected with Bordetella pertussis.
Coleman MM; Finlay CM; Moran B; Keane J; Dunne PJ; Mills KH
FEMS Immunol Med Microbiol; 2012 Apr; 64(3):413-24. PubMed ID: 22211712
[TBL] [Abstract][Full Text] [Related]
38. Reduced CD4+,CD25- T cell sensitivity to the suppressive function of CD4+,CD25high,CD127 -/low regulatory T cells in patients with active systemic lupus erythematosus.
Venigalla RK; Tretter T; Krienke S; Max R; Eckstein V; Blank N; Fiehn C; Ho AD; Lorenz HM
Arthritis Rheum; 2008 Jul; 58(7):2120-30. PubMed ID: 18576316
[TBL] [Abstract][Full Text] [Related]
39. Human epithelial ovarian carcinoma cell-derived cytokines cooperatively induce activated CD4+CD25-CD45RA+ naïve T cells to express forkhead box protein 3 and exhibit suppressive ability in vitro.
Zhao X; Ye F; Chen L; Lu W; Xie X
Cancer Sci; 2009 Nov; 100(11):2143-51. PubMed ID: 19673890
[TBL] [Abstract][Full Text] [Related]
40. Fine-tuning of regulatory T cell function: the role of calcium signals and naive regulatory T cells for regulatory T cell deficiency in multiple sclerosis.
Schwarz A; Schumacher M; Pfaff D; Schumacher K; Jarius S; Balint B; Wiendl H; Haas J; Wildemann B
J Immunol; 2013 May; 190(10):4965-70. PubMed ID: 23576680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
